Post by slushy on Oct 10, 2013 17:26:27 GMT -5
This is a trending article on YMB: finance.yahoo.com/mbview/threadview/?&bn=0243242e-59fb-3abc-8d27-962c7bf26a1d&tid=1381431560086-c66f4405-9cb1-4979-ad08-925348c3c448&tls=la%2Cd%2C10%2C3
Basically it's a job posting for Sanofi that sounds an awful lot like it would be for MNKD. Highlight below:
Job Title: Director, Value & Access - Insulin, Global Diabetes Division
Interest Category: Managed Markets
Department: Global Diabetes Market Access
Purpose of the role:
The purpose of the role is to serve as the Value & Access Sub-team Leader for a critically important asset currently in phase 3 development within the Insulin franchise. The V&A Sub-team Leader reports to the head of Diabetes V&A and priorities and deliverables are aligned with the Global Project Leader for the Asset.
Are there any other diabetes products in Phase 3? This seems to give a lot of weight to the Sanofi rumors... but what are the thoughts of the experts on this board?
Basically it's a job posting for Sanofi that sounds an awful lot like it would be for MNKD. Highlight below:
Job Title: Director, Value & Access - Insulin, Global Diabetes Division
Interest Category: Managed Markets
Department: Global Diabetes Market Access
Purpose of the role:
The purpose of the role is to serve as the Value & Access Sub-team Leader for a critically important asset currently in phase 3 development within the Insulin franchise. The V&A Sub-team Leader reports to the head of Diabetes V&A and priorities and deliverables are aligned with the Global Project Leader for the Asset.
Are there any other diabetes products in Phase 3? This seems to give a lot of weight to the Sanofi rumors... but what are the thoughts of the experts on this board?